KalVista Pharmaceuticals, Inc.

DEUTSCHE BANK AG\ KALV

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/11/2026

Shares

35,091

Value ($000)

567

Weight

0.0%

2018 Q2 - 2025 Q4 (27 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/11/2026	567	0.0%	35,091	12/31/2025
2025 Q3	11/13/2025	369	0.0%	30,255	9/30/2025
2025 Q2	8/12/2025	322	0.0%	28,474	6/30/2025
2025 Q1	5/9/2025	371	0.0%	32,126	3/31/2025
2024 Q4	6/30/2025	304	0.0%	35,841	12/31/2024
2024 Q3	6/26/2025	254	0.0%	21,918	9/30/2024
2024 Q2	6/12/2025	187	0.0%	15,858	6/30/2024
2024 Q1	6/2/2025	145	0.0%	12,196	3/31/2024
2023 Q4	2/14/2024	141	0.0%	11,544	12/31/2023
2023 Q3	11/24/2023	114	0.0%	11,879	9/30/2023
2023 Q2	8/14/2023	84	0.0%	9,387	6/30/2023
2023 Q1	5/15/2023	119	0.0%	15,123	3/31/2023
2022 Q4	2/13/2023	70	0.0%	10,400	12/31/2022
2022 Q3	11/14/2022	149	0.0%	10,238	9/30/2022
2022 Q2	8/11/2022	105	0.0%	10,633	6/30/2022
2022 Q1	5/13/2022	189	0.0%	12,852	3/31/2022
2021 Q4	2/16/2022	186	0.0%	14,078	12/31/2021
2021 Q3	11/4/2021	274	0.0%	15,708	9/30/2021
2021 Q2	8/11/2021	289	0.0%	12,091	6/30/2021
2021 Q1	5/13/2021	320	0.0%	12,475	3/31/2021
2020 Q4	2/16/2021	203	0.0%	10,712	12/31/2020
2020 Q3	11/12/2020	95	0.0%	7,596	9/30/2020
2020 Q2	8/13/2020	82	0.0%	6,747	6/30/2020
2020 Q1	5/14/2020	33	0.0%	4,336	3/31/2020
2019 Q4	2/14/2020	81	0.0%	4,598	12/31/2019
2018 Q3	12/21/2021	179	—	8,091	9/30/2018
2018 Q2	4/21/2020	205	—	25,228	6/30/2018